Menu
GeneBe

SLC25A19

solute carrier family 25 member 19, the group of Solute carrier family 25

Basic information

Region (hg38): 17:75272980-75289510

Previous symbols: [ "MCPHA" ]

Links

ENSG00000125454NCBI:60386OMIM:606521HGNC:14409Uniprot:Q9HC21AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Strong), mode of inheritance: AR
  • Amish lethal microcephaly (Supportive), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Supportive), mode of inheritance: AR
  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Strong), mode of inheritance: AR
  • Leigh syndrome (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thiamine metabolism dysfunction syndrome 4; Microcephaly, Amish typeARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic12185364; 19798730; 20583149
High fat diet has been reported as being beneficial

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC25A19 gene.

  • not provided (124 variants)
  • Amish lethal microcephaly (35 variants)
  • not specified (23 variants)
  • Inborn genetic diseases (16 variants)
  • Progressive demyelinating neuropathy with bilateral striatal necrosis (10 variants)
  • Progressive demyelinating neuropathy with bilateral striatal necrosis;Amish lethal microcephaly (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A19 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
25
clinvar
2
clinvar
27
missense
3
clinvar
50
clinvar
3
clinvar
56
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
3
4
7
non coding
5
clinvar
19
clinvar
24
clinvar
48
Total 1 3 56 47 26

Highest pathogenic variant AF is 0.0000197

Variants in SLC25A19

This is a list of pathogenic ClinVar variants found in the SLC25A19 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-75273014-A-C Amish lethal microcephaly Benign (Jan 12, 2018)325061
17-75273043-G-A Amish lethal microcephaly Uncertain significance (Jan 13, 2018)889454
17-75273067-G-A Amish lethal microcephaly Uncertain significance (Jan 13, 2018)889455
17-75273150-G-A Amish lethal microcephaly Likely benign (Jan 13, 2018)889456
17-75273159-T-C Amish lethal microcephaly Uncertain significance (Jan 13, 2018)889457
17-75273177-G-C Amish lethal microcephaly Benign (Jun 16, 2018)325062
17-75273251-C-T Amish lethal microcephaly Benign/Likely benign (Apr 16, 2019)325063
17-75273287-C-T Amish lethal microcephaly Benign (Mar 06, 2018)890139
17-75273338-C-G Amish lethal microcephaly Uncertain significance (Jan 13, 2018)325064
17-75273355-C-G Amish lethal microcephaly Likely benign (Sep 29, 2019)890140
17-75273447-G-A SLC25A19-related disorder Likely benign (Jan 22, 2024)3045153
17-75273449-A-G not specified • Amish lethal microcephaly • Progressive demyelinating neuropathy with bilateral striatal necrosis Benign (Jul 15, 2021)130327
17-75273455-C-T Uncertain significance (Aug 23, 2022)2162573
17-75273475-C-A Uncertain significance (Jun 24, 2022)2005002
17-75273484-G-T Amish lethal microcephaly Uncertain significance (Jun 14, 2016)325065
17-75273496-G-A not specified Likely benign (Nov 08, 2022)436747
17-75273504-C-T Progressive demyelinating neuropathy with bilateral striatal necrosis Pathogenic (Jul 08, 2022)1695342
17-75273508-C-T Likely benign (Dec 20, 2023)785582
17-75273509-G-A Inborn genetic diseases Uncertain significance (Oct 04, 2022)2394315
17-75273509-G-C Inborn genetic diseases Likely benign (Jun 25, 2021)2231350
17-75273524-C-A Inborn genetic diseases Uncertain significance (Sep 26, 2023)3163613
17-75273535-G-A Likely benign (Jun 28, 2018)755591
17-75273545-A-T Progressive demyelinating neuropathy with bilateral striatal necrosis Pathogenic (Jul 08, 2022)1695339
17-75273572-A-C Amish lethal microcephaly • SLC25A19-related disorder Conflicting classifications of pathogenicity (Feb 27, 2024)596497
17-75273576-C-T Uncertain significance (Aug 01, 2022)1927596

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC25A19protein_codingprotein_codingENST00000402418 616519
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6490.3501257360121257480.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5871711940.8810.00001212082
Missense in Polyphen3154.5640.56814564
Synonymous0.5397480.10.9230.00000547654
Loss of Function2.68212.00.1665.19e-7157

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00007930.0000791
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mitochondrial transporter mediating uptake of thiamine pyrophosphate (ThPP) into mitochondria. {ECO:0000269|PubMed:18280798}.;
Disease
DISEASE: Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type (THMD4) [MIM:613710]: A disease characterized by recurrent episodes of flaccid paralysis and encephalopathy associated with bilateral striatal necrosis and chronic progressive polyneuropathy. {ECO:0000269|PubMed:19798730}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Vitamin B1 (thiamin) metabolism;Purine metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Pyrimidine metabolism;Metabolism of vitamins and cofactors (Consensus)

Recessive Scores

pRec
0.178

Intolerance Scores

loftool
0.128
rvis_EVS
-0.43
rvis_percentile_EVS
25.37

Haploinsufficiency Scores

pHI
0.137
hipred
Y
hipred_score
0.551
ghis
0.590

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.460

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc25a19
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
deoxynucleotide transport;thiamine pyrophosphate transmembrane transport;thiamine-containing compound metabolic process;thiamine transmembrane transport
Cellular component
nucleus;mitochondrial inner membrane;integral component of mitochondrial inner membrane
Molecular function
thiamine transmembrane transporter activity;deoxynucleotide transmembrane transporter activity;thiamine pyrophosphate transmembrane transporter activity